A Prospective Study on Evaluation of Efficacy of Combination Therapy of Tamsulosin and Deflazacort In Ureteric Stone Expulsion
E.Sam Jeeva Kumar 1*,Amitha Mary Samson2, Avani S L2, Pranith P L2, Catherine Samantha 2, Dr.Prasobh G R3
1.Department of Pharmacy Practice, Sree Krishna
College of Pharmacy and Research Centre,
Thiruvananthapuram, Kerala, India
The patients with ureteric stone are increasing day by day all over the world. A ureteric stone is a mineral mass in the ureter which may or may not originated in the kidney and travelled down to the ureter. The presence of stone in ureter causes inflammation and edema. There are mainly four types of ureteric stone such as Calcium stones, Uric acid stones, Struvite stone, Cystine stone. About 23-53% of spontaneous stone expulsion occurs where the size of stone is 5-10mm diameter. Tamsulosin is an alpha 1 adrenergic blocker which has a spasmolytic action and thus hasten stone expulsion. Deflazacort is a corticosteroid prodrug which acts on the glucocorticoid receptor to show an anti-inflammatory effect. Deflazacort decreases the edema and when prescribed along with alpha 1 adrenergic receptor blocker it facilitate the expulsion of calculi. This study was conducted in 20 patients diagnosed with ureteric calculi. The study was conducted by using suitable proforma for collecting various data’s like site of stones, presence of hydronephrosis, signs and symptoms. Health related quality of life of the patients with ureteric calculi under the treatment of Tamsulosin and Deflazacort combination were assessed by using Wisconsin Stone-QOL questionnaire. As counselling aid patients information leaflet was provided. The patients were asked to review after 10 days of taking the medication. At the end of the study all the parameters and scores were compared with baseline to the end of the study. In our study we analyzed that the data collected from 20 patients diagnosed with ureteric calculi accessed the improvement of quality of life of patients under the treatment of Tamsulosin and Deflazacort combination by using Wisconsin Stone-QOL questionnaire. The observed difference before and after the treatment with Tamsulosin and Deflazacort was statistically significant (p<0.05). It is found that there was a significant improvement in the quality of life of the patient after combination treatment with Tamsulosin and Deflazacort. By evaluating this pilot study, we conclude that the medical expulsive therapy using Tamsulosin and Deflazacort combination is a first line therapy in management of ureteric stones. It is also found that the combination therapy of Tamsulosin and Deflazacort have good expulsion rate.
Keywords: Tamsulosin and Deflazacort, ureteric stone